Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Velcade NDA submitted for multiple myeloma

Jan. 24, 2003

Yamanouchi reports novel VEGF inhibitors

Jan. 24, 2003

RK-0202 enters phase II evaluation in oral mucositis

Jan. 23, 2003

CYC-202 enters phase IIa trials in breast and lung cancers

Jan. 22, 2003

E.U. approves Taxotere in combination with cisplatin for first-line NSCLC treatment

Jan. 22, 2003

Pierre Fabre presents novel inhibitors of protein prenyltransferases

Jan. 22, 2003

Agouron discovers novel nonpeptide GnRH antagonists

Jan. 22, 2003

Vascular targeting agent ZD-6126 exerts significant antitumor activity at well-tolerated doses

Jan. 21, 2003

ABI-007 receives fast track status for metastatic breast cancer

Jan. 21, 2003

New antitumor agents prepared and tested by French team

Jan. 21, 2003

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...